Emergent Biosolutions EBS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $6.8M-90.0% | —— | $51.2M-55.4% | -$12M+95.8% | $68M+656% | ||
| $23.5M-7.5% | $23.5M-9.6% | $23.4M-11.4% | $23.5M-17.5% | $25.4M-9.0% | ||
| $1.9M+26.7% | $5.3M+23.3% | $4.8M+109% | $4.6M-16.4% | $1.5M-74.6% | ||
| -$33.8M-202% | $77.7M— | $0-100% | $106.4M— | -$11.2M+82.1% | ||
| $2.4M-33.3% | $3.9M+129% | $3.4M-41.4% | $2.9M-37.0% | $3.6M-66.7% | ||
| -$2.4M-104% | —— | —— | $17.2M+474% | $59.5M+651% | ||
| $9M— | $9.1M— | $8.9M— | $6.9M— | $0— | ||
| -$11.4M-2,750% | -$113.9M— | -$15.9M+91.2% | -$6.4M+87.4% | -$400K-101% | ||
| -$47.6M-201% | —— | —— | $118.2M+1,578% | $47.2M+244% | ||
| -$36.2M-145% | $73.8M— | $0-100% | $103.5M— | -$14.8M+79.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Emergent Biosolutions generate?
- Emergent Biosolutions (EBS) generated $150.3M in operating cash flow over the trailing twelve months.
- What is Emergent Biosolutions's free cash flow?
- After $12.6M of capital expenditures, Emergent Biosolutions's free cash flow was $141.1M over the trailing twelve months, up 310.0% year over year.
- Where does Emergent Biosolutions's cash flow data come from?
- Every line is extracted from Emergent Biosolutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
